People with high risk of obstructive sleep apnea presented with significant changes in key arteries indicative of accelerated vascular aging, a known contributor to cardiovascular disease (CVD).
Individuals at high risk of obstructive sleep apnea (OSA) may be at increased risk of accelerated vascular aging, a known contributor to cardiovascular disease, according to study findings published in the Journal of the American Heart Association.
As a highly prevalent condition affecting up to 49% of men and 23% of women older than 40 years, OSA has been identified as a major risk factor for cardiovascular diseases, including coronary artery disease, heart failure, and stroke. Although the link is widely known, researchers note that the mechanisms underlying the association are “incompletely understood,” with current research suggesting that increased cardiovascular risk in individuals with OSA may be mediated by accelerated vascular aging.
“Vascular aging is characterized by accumulation of functional and structural changes of vessels throughout life….key manifestations of vascular aging include arterial stiffening, greater carotid intima-media thickness, and carotid diameter enlargement,” explained the study authors.
Seeking to further investigate the association between OSA and several manifestations indicative of vascular aging, the researchers assessed data of 2 community-based cohort studies from 2 European countries: the Paris Prospective Study 3 (PPS3) in France (n = 6840; 62% men; mean [SD] age, 59.5 [6.2] years) and the Maastricht Study in the Netherlands (n = 1775; 51% men; mean age, 58.9 [8.1] years).
All participants were free of previous cardiovascular disease, with risk of OSA determined via the Berlin questionnaire. Assessed manifestations of vascular aging included carotid artery properties (carotid intima-media thickness, Young’s elastic modulus, carotid-femoral pulse wave velocity, carotid pulse wave velocity, carotid diameter using high precision ultrasound echography), with carotid-femoral pulse wave velocity of the Maastricht Study also assessed separately.
High risk of OSA prevalence was identified in 16.8% (n = 1150) of the PPS3 cohort and in 23.8% (n = 423) of the Maastricht Study. Moreover, those at high risk of OSA were significantly associated with markedly higher levels of all vascular aging variables than low-risk counterparts, after adjustment for age, sex, smoking, education level, total cholesterol, diabetes , heart rate, and study site:
"Our findings could explain, in part, why people with sleep apnea have an increased risk of mortality and cardiovascular diseases," said study author Quentin Lisan, MD, PhD, Department of Head and Neck Surgery, Foch Hospital, in a statement.
Acknowledging limitations of the study, including the lack of polysomnography to identify sleep apnea and its primary focus on White Europeans, Lisan said that future research should assess the effectiveness of continuous positive airway pressure on slowing or reversing vascular aging, as these devices have been shown to significantly decrease the risk of heart failure.
In the meantime, Lisan recommended greater utilization of noninvasive, low-cost sleep apnea tests to proactively track vascular aging and for people with the condition to manage and improve aspects of their vascular health, such as cholesterol and blood pressure,t o optimal levels.
Reference
Lisan Q, van Sloten T, Boutouyrie P, et al. Sleep apnea is associated with accelerated vascular aging: results from 2 European community-based cohort studies. J Am Heart Assoc. Published online July 26, 2021. doi:10.1161/JAHA.120.021318
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More